Body size, physical activity and risk of colorectal cancer with or without the CpG island methylator phenotype (CIMP).
<h4>Background</h4>We investigated how body size and physical activity influence the risk of the CpG island methylator phenotype (CIMP) in colorectal cancer (CRC).<h4>Methods</h4>In the Netherlands Cohort Study (n = 120,852), risk factors were self-reported at baseline in 198...
Guardado en:
Autores principales: | Laura A E Hughes, Colinda C J M Simons, Piet A van den Brandt, R Alexandra Goldbohm, Anton F de Goeij, Adriaan P de Bruïne, Manon van Engeland, Matty P Weijenberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5be0c2dd2ec34f4ca33ce669e28c41a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lamin A/C is a risk biomarker in colorectal cancer.
por: Naomi D Willis, et al.
Publicado: (2008) -
Comparison of CpG island methylator phenotype (CIMP) frequency in colon cancer using different probe- and gene-specific scoring alternatives on recommended multi-gene panels.
por: Marianne Berg, et al.
Publicado: (2014) -
Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
por: Chloe Goldsmith, et al.
Publicado: (2021) -
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen W, et al.
Publicado: (2021) -
DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis
por: Lars Tögel, et al.
Publicado: (2018)